These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7782766

  • 1. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.
    Muller CP, Beauverger P, Schneider F, Jung G, Brons NH.
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1371-80. PubMed ID: 7782766
    [Abstract] [Full Text] [Related]

  • 2. [Systemic B-cell response in the mouse after mucosal immunization with measles virus].
    Muller CP, Brons NH.
    Immun Infekt; 1994 Jun; 22(3):125-6. PubMed ID: 7927470
    [Abstract] [Full Text] [Related]

  • 3. Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus.
    Etchart N, Wild F, Kaiserlian D.
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2471-8. PubMed ID: 8887480
    [Abstract] [Full Text] [Related]

  • 4. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 5. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
    Price GA, Russell MW, Cornelissen CN.
    Infect Immun; 2005 Jul 25; 73(7):3945-53. PubMed ID: 15972481
    [Abstract] [Full Text] [Related]

  • 6. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J, Adamsson J, Harandi AM.
    Scand J Immunol; 2008 May 25; 67(5):431-40. PubMed ID: 18298617
    [Abstract] [Full Text] [Related]

  • 7. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
    Wu HY, Russell MW.
    Infect Immun; 1993 Jan 25; 61(1):314-22. PubMed ID: 8418053
    [Abstract] [Full Text] [Related]

  • 8. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, Neutra MR.
    J Immunol; 2002 Jul 01; 169(1):566-74. PubMed ID: 12077289
    [Abstract] [Full Text] [Related]

  • 9. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
    Hirabayashi Y, Kurata H, Funato H, Nagamine T, Aizawa C, Tamura S, Shimada K, Kurata T.
    Vaccine; 1990 Jun 01; 8(3):243-8. PubMed ID: 2363302
    [Abstract] [Full Text] [Related]

  • 10. A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.
    Chabot S, Brewer A, Lowell G, Plante M, Cyr S, Burt DS, Ward BJ.
    Vaccine; 2005 Feb 03; 23(11):1374-83. PubMed ID: 15661386
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.
    Microbiol Immunol; 2008 Feb 03; 52(2):55-63. PubMed ID: 18380802
    [Abstract] [Full Text] [Related]

  • 12. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.
    Glenn GM, Scharton-Kersten T, Vassell R, Mallett CP, Hale TL, Alving CR.
    J Immunol; 1998 Oct 01; 161(7):3211-4. PubMed ID: 9759833
    [Abstract] [Full Text] [Related]

  • 13. Combined oral/nasal immunization protects mice from Sendai virus infection.
    Nedrud JG, Liang XP, Hague N, Lamm ME.
    J Immunol; 1987 Nov 15; 139(10):3484-92. PubMed ID: 2824609
    [Abstract] [Full Text] [Related]

  • 14. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
    Wu HY, Russell MW.
    Vaccine; 1998 Nov 15; 16(2-3):286-92. PubMed ID: 9607044
    [Abstract] [Full Text] [Related]

  • 15. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity.
    Wu HY, Russell MW.
    Vaccine; 1994 Nov 15; 12(3):215-22. PubMed ID: 8165853
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins.
    Albu DI, Jones-Trower A, Woron AM, Stellrecht K, Broder CC, Metzger DW.
    J Virol; 2003 May 15; 77(10):5589-97. PubMed ID: 12719551
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y, Kumada H, Hamada N, Haishima Y, Ozono S, Isaka M, Yasuda Y, Tochikubo K, Umemoto T.
    Oral Microbiol Immunol; 2007 Dec 15; 22(6):374-80. PubMed ID: 17949339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.